Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Muscular Dystrophy Association

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 5
Rounds per year 0.08
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
Summary

In 1950 was created Muscular Dystrophy Association, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Chicago. The venture was found in North America in United States.

The top activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 100 thousands - 1 million dollars.

The typical case for the fund is to invest in rounds with 1 participant. Despite the Muscular Dystrophy Association, startups are often financed by UCB Ventures, Temasek Holdings, Lightstone Ventures.

We can highlight the next thriving fund investment areas, such as Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Locana Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Muscular Dystrophy Association:
Typical Co-investors
Muscular Dystrophy Association is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Muscular Dystrophy Association:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Continental Bank -
Cope Ventures -
Daiwa Energy Infrastructure -
Forticom Latvia, Riga, Vidzeme
Gund Investment, LLC New Jersey, Princeton, United States
Hamashin Lease Hamamatsu, Japan, Shizuoka Prefecture
ISF, Inc. Florida, Jacksonville, United States
Kyber Capital -
Miyako Capital Japan, Kyoto, Kyoto Prefecture
ModiQuest B.V. -
Pilot Grove -
RapidTainment Cham, Switzerland, Zug
SAS Cary, North Carolina, United States
Securian Financial Group Minnesota, Saint Paul, United States
The Net Group -
Transamerica Cedar Rapids, Iowa, United States
Updata Partners District of Columbia, United States, Washington
Xuanshi Tiancheng -
Zhongtianlida Feng Tou Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

PathMaker Neurosystems

Biotechnology
Health Care
Life Science
Medical
$600K17 Jan 2023 Boston, Massachusetts, United States

Myosana Therapeutics

Biotechnology
Therapeutics
$5M07 Dec 2022 Seattle, Washington, United States

Biotechnology
Health Care
Therapeutics
$550K12 Jun 2019 San Diego, California, United States

Amicus Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$186K07 Feb 2012 New Jersey, United States

Asklepios BioPharmaceutical

Biopharma
Biotechnology
Health Care
Manufacturing
Medical
Medical Device
$2M12 Dec 2006 North Carolina, United States

Asklepios BioPharmaceutical

Biopharma
Biotechnology
Health Care
Manufacturing
Medical
Medical Device
$1M01 Jan 2004 North Carolina, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Muscular Dystrophy Association?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: